Assessment of Benzodiazepine Receptors Using Iodine-123–Labeled Iomazenil Single-Photon Emission Computed Tomography in Patients With Ischemic Cerebrovascular Disease A Comparison With PET Study

Background and Purpose [ 123 I]Iomazenil (IMZ) is a tracer used for single-photon emission computed tomography (SPECT) that has the characteristics of selectively binding to central benzodiazepine receptors (BZR) in the neuron membrane. To determine whether IMZ SPECT provides new information on asse...

Full description

Saved in:
Bibliographic Details
Published inStroke (1970) Vol. 28; no. 9; pp. 1776 - 1782
Main Authors Dong, Yun, Fukuyama, Hidenao, Nabatame, Hidehiko, Yamauchi, Hiroshi, Shibasaki, Hiroshi, Yonekura, Yoshiharu
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 01.09.1997
Subjects
Online AccessGet full text
ISSN0039-2499
1524-4628
DOI10.1161/01.STR.28.9.1776

Cover

Loading…
Abstract Background and Purpose [ 123 I]Iomazenil (IMZ) is a tracer used for single-photon emission computed tomography (SPECT) that has the characteristics of selectively binding to central benzodiazepine receptors (BZR) in the neuron membrane. To determine whether IMZ SPECT provides new information on assessing neuronal damage after ischemic insult to the brain, we compared IMZ SPECT images with the cerebral blood flow (CBF), cerebral metabolic rate of oxygen (CMRO 2 ), and cerebral metabolic rate of glucose (CMRGlc) studied by positron emission tomography in the chronic stage of ischemic stroke. Methods Five patients (male; mean age, 63.2±6.0 years) with ischemic cerebrovascular disease and 6 age- and sex-matched normal control subjects were studied. IMZ images obtained 180 minutes after injection were analyzed for BZR binding, and these images were compared with the CBF, CMRO 2 , and CMRGlc obtained by positron emission tomography in the same perfusion areas both visually and quantitatively. Results In the visual analysis of data obtained from 4 patients with subcortical infarction, decreased IMZ accumulation was observed locally in the overlying normal-appearing cortices of the affected hemisphere, where extensive hypoperfusion and hypometabolism were seen on the images of CBF, CMRO 2 , and CMRGlc. The regional relative IMZ uptake (regional to cerebellar ratio) for all 5 patients was significantly correlated with the corresponding regional CMRO 2 values ( r =.45, P <.05). However, no significant correlation was found of the IMZ uptake with either the regional CBF or the regional CMRGlc. Conclusions The use of IMZ SPECT provides new information on the neuronal alteration induced by chronic ischemic cerebrovascular disease.
AbstractList [123I]Iomazenil (IMZ) is a tracer used for single-photon emission computed tomography (SPECT) that has the characteristics of selectively binding to central benzodiazepine receptors (BZR) in the neuron membrane. To determine whether IMZ SPECT provides new information on assessing neuronal damage after ischemic insult to the brain, we compared IMZ SPECT images with the cerebral blood flow (CBF), cerebral metabolic rate of oxygen (CMRO2), and cerebral metabolic rate of glucose (CMRGlc) studied by position emission tomography in the chronic stage of ischemic stroke.BACKGROUND AND PURPOSE[123I]Iomazenil (IMZ) is a tracer used for single-photon emission computed tomography (SPECT) that has the characteristics of selectively binding to central benzodiazepine receptors (BZR) in the neuron membrane. To determine whether IMZ SPECT provides new information on assessing neuronal damage after ischemic insult to the brain, we compared IMZ SPECT images with the cerebral blood flow (CBF), cerebral metabolic rate of oxygen (CMRO2), and cerebral metabolic rate of glucose (CMRGlc) studied by position emission tomography in the chronic stage of ischemic stroke.Five patients (male; mean age, 63.2 +/- 6.0 years) with ischemic cerebrovascular disease and 6 age- and sex-matched normal control subjects were studied. IMZ images obtained 180 minutes after injection were analyzed for BZR binding, and these images were compared with the CBF, CMRO2, and CMRGlc obtained by position emission tomography in the same perfusion areas both visually and quantitatively.METHODSFive patients (male; mean age, 63.2 +/- 6.0 years) with ischemic cerebrovascular disease and 6 age- and sex-matched normal control subjects were studied. IMZ images obtained 180 minutes after injection were analyzed for BZR binding, and these images were compared with the CBF, CMRO2, and CMRGlc obtained by position emission tomography in the same perfusion areas both visually and quantitatively.In the visual analysis of data obtained from 4 patients with subcortical infarction, decreased IMZ accumulation was observed locally in the overlying normal-appearing cortices of the affected hemisphere, where extensive hypoperfusion and hypometabolism were seen on the images of CBF, CMRO2, and CMRGlc. The regional relative IMZ uptake (regional to cerebellar ratio) for all 5 patients was significantly correlated with the corresponding regional CMRO2 values (r = .45, P < .05). However, no significant correlation was found of the IMZ uptake with either the regional CBF or the regional CMRGlc.RESULTSIn the visual analysis of data obtained from 4 patients with subcortical infarction, decreased IMZ accumulation was observed locally in the overlying normal-appearing cortices of the affected hemisphere, where extensive hypoperfusion and hypometabolism were seen on the images of CBF, CMRO2, and CMRGlc. The regional relative IMZ uptake (regional to cerebellar ratio) for all 5 patients was significantly correlated with the corresponding regional CMRO2 values (r = .45, P < .05). However, no significant correlation was found of the IMZ uptake with either the regional CBF or the regional CMRGlc.The use of IMZ SPECT provides new information on the neuronal alteration induced by chronic ischemic cerebrovascular disease.CONCLUSIONSThe use of IMZ SPECT provides new information on the neuronal alteration induced by chronic ischemic cerebrovascular disease.
Background and Purpose [ 123 I]Iomazenil (IMZ) is a tracer used for single-photon emission computed tomography (SPECT) that has the characteristics of selectively binding to central benzodiazepine receptors (BZR) in the neuron membrane. To determine whether IMZ SPECT provides new information on assessing neuronal damage after ischemic insult to the brain, we compared IMZ SPECT images with the cerebral blood flow (CBF), cerebral metabolic rate of oxygen (CMRO 2 ), and cerebral metabolic rate of glucose (CMRGlc) studied by positron emission tomography in the chronic stage of ischemic stroke. Methods Five patients (male; mean age, 63.2±6.0 years) with ischemic cerebrovascular disease and 6 age- and sex-matched normal control subjects were studied. IMZ images obtained 180 minutes after injection were analyzed for BZR binding, and these images were compared with the CBF, CMRO 2 , and CMRGlc obtained by positron emission tomography in the same perfusion areas both visually and quantitatively. Results In the visual analysis of data obtained from 4 patients with subcortical infarction, decreased IMZ accumulation was observed locally in the overlying normal-appearing cortices of the affected hemisphere, where extensive hypoperfusion and hypometabolism were seen on the images of CBF, CMRO 2 , and CMRGlc. The regional relative IMZ uptake (regional to cerebellar ratio) for all 5 patients was significantly correlated with the corresponding regional CMRO 2 values ( r =.45, P <.05). However, no significant correlation was found of the IMZ uptake with either the regional CBF or the regional CMRGlc. Conclusions The use of IMZ SPECT provides new information on the neuronal alteration induced by chronic ischemic cerebrovascular disease.
[123I]Iomazenil (IMZ) is a tracer used for single-photon emission computed tomography (SPECT) that has the characteristics of selectively binding to central benzodiazepine receptors (BZR) in the neuron membrane. To determine whether IMZ SPECT provides new information on assessing neuronal damage after ischemic insult to the brain, we compared IMZ SPECT images with the cerebral blood flow (CBF), cerebral metabolic rate of oxygen (CMRO2), and cerebral metabolic rate of glucose (CMRGlc) studied by position emission tomography in the chronic stage of ischemic stroke. Five patients (male; mean age, 63.2 +/- 6.0 years) with ischemic cerebrovascular disease and 6 age- and sex-matched normal control subjects were studied. IMZ images obtained 180 minutes after injection were analyzed for BZR binding, and these images were compared with the CBF, CMRO2, and CMRGlc obtained by position emission tomography in the same perfusion areas both visually and quantitatively. In the visual analysis of data obtained from 4 patients with subcortical infarction, decreased IMZ accumulation was observed locally in the overlying normal-appearing cortices of the affected hemisphere, where extensive hypoperfusion and hypometabolism were seen on the images of CBF, CMRO2, and CMRGlc. The regional relative IMZ uptake (regional to cerebellar ratio) for all 5 patients was significantly correlated with the corresponding regional CMRO2 values (r = .45, P < .05). However, no significant correlation was found of the IMZ uptake with either the regional CBF or the regional CMRGlc. The use of IMZ SPECT provides new information on the neuronal alteration induced by chronic ischemic cerebrovascular disease.
Author Yonekura, Yoshiharu
Yamauchi, Hiroshi
Fukuyama, Hidenao
Nabatame, Hidehiko
Dong, Yun
Shibasaki, Hiroshi
Author_xml – sequence: 1
  givenname: Yun
  surname: Dong
  fullname: Dong, Yun
  organization: From the Departments of Brain Pathophysiology (Y.D., H.F., H.S.) and Neurology (H.Y.), Faculty of Medicine, Kyoto University; Department of Neurology, Shiga Medical Center for Adult Disease (H.N.), Moriyama, Shiga; and Biomedical Center, Fukui Medical School (Y.Y.), Fukui, Japan
– sequence: 2
  givenname: Hidenao
  surname: Fukuyama
  fullname: Fukuyama, Hidenao
  organization: From the Departments of Brain Pathophysiology (Y.D., H.F., H.S.) and Neurology (H.Y.), Faculty of Medicine, Kyoto University; Department of Neurology, Shiga Medical Center for Adult Disease (H.N.), Moriyama, Shiga; and Biomedical Center, Fukui Medical School (Y.Y.), Fukui, Japan
– sequence: 3
  givenname: Hidehiko
  surname: Nabatame
  fullname: Nabatame, Hidehiko
  organization: From the Departments of Brain Pathophysiology (Y.D., H.F., H.S.) and Neurology (H.Y.), Faculty of Medicine, Kyoto University; Department of Neurology, Shiga Medical Center for Adult Disease (H.N.), Moriyama, Shiga; and Biomedical Center, Fukui Medical School (Y.Y.), Fukui, Japan
– sequence: 4
  givenname: Hiroshi
  surname: Yamauchi
  fullname: Yamauchi, Hiroshi
  organization: From the Departments of Brain Pathophysiology (Y.D., H.F., H.S.) and Neurology (H.Y.), Faculty of Medicine, Kyoto University; Department of Neurology, Shiga Medical Center for Adult Disease (H.N.), Moriyama, Shiga; and Biomedical Center, Fukui Medical School (Y.Y.), Fukui, Japan
– sequence: 5
  givenname: Hiroshi
  surname: Shibasaki
  fullname: Shibasaki, Hiroshi
  organization: From the Departments of Brain Pathophysiology (Y.D., H.F., H.S.) and Neurology (H.Y.), Faculty of Medicine, Kyoto University; Department of Neurology, Shiga Medical Center for Adult Disease (H.N.), Moriyama, Shiga; and Biomedical Center, Fukui Medical School (Y.Y.), Fukui, Japan
– sequence: 6
  givenname: Yoshiharu
  surname: Yonekura
  fullname: Yonekura, Yoshiharu
  organization: From the Departments of Brain Pathophysiology (Y.D., H.F., H.S.) and Neurology (H.Y.), Faculty of Medicine, Kyoto University; Department of Neurology, Shiga Medical Center for Adult Disease (H.N.), Moriyama, Shiga; and Biomedical Center, Fukui Medical School (Y.Y.), Fukui, Japan
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2812255$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/9303025$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1u1DAUhS1UVKaFPRskLxC7BP8kTrws0wIjjUTVTsUycjw3HaPEDr4JUrviHfoSfS6eBI866gKJla1zvmPr3nNCjnzwQMhbznLOFf_IeH69ucpFneucV5V6QRa8FEVWKFEfkQVjUmei0PoVOUH8wRgTsi6PybGWTDJRLsjjGSIgDuAnGjr6Cfx92DpzD6PzQK_AwjiFiPQGnb-lq-R5yLiQf34_rE0LPWyTOCTeu55eJ6aH7HIXpuDpxeAQXboswzDOUyI3YQi30Yy7O-o8vTSTS98i_e6mHV2h3cHgLF1ChDaGXwbt3JtIzx2CQXhNXnamR3hzOE_JzeeLzfJrtv72ZbU8W2dWlnrKOJOV4mCY4hq2BZgk8EonEYq6VSUvtQLFbKtb1XVlYaQUlSm1MJ2uK1HIU_Lh6d0xhp8z4NSkMSz0vfEQZmwqLXRdS5XAdwdwbgfYNmN0g4l3zWG1yX9_8NMkpu-i8dbhMyZqLkS5x9gTZmNAjNA9E5w1-44bxpvUcQo0utl3nCLqn4h1U1pm8FM0rv9_8C-zWK4q
CODEN SJCCA7
CitedBy_id crossref_primary_10_1093_brain_awn175
crossref_primary_10_1007_s12149_010_0421_7
crossref_primary_10_2967_jnumed_110_084186
crossref_primary_10_1002_syn_10217
crossref_primary_10_1016_S0033_8389_05_70326_2
crossref_primary_10_2335_scs_39_341
crossref_primary_10_1038_jcbfm_2013_188
crossref_primary_10_1097_RLU_0b013e31823ea69f
crossref_primary_10_1016_j_bandl_2024_105481
crossref_primary_10_1002_ana_21104
crossref_primary_10_1007_s12149_023_01825_0
crossref_primary_10_1093_brain_awr033
crossref_primary_10_1097_MD_0000000000025617
crossref_primary_10_1159_000480228
crossref_primary_10_1111_j_1552_6569_2004_tb00212_x
crossref_primary_10_1016_j_cpet_2009_12_005
crossref_primary_10_1016_j_cpet_2009_12_007
crossref_primary_10_1524_ract_92_2_119_27464
crossref_primary_10_2967_jnumed_111_087940
crossref_primary_10_1016_j_nicl_2022_103277
crossref_primary_10_1007_BF03164903
crossref_primary_10_1016_j_brainres_2006_02_139
crossref_primary_10_1007_s12149_016_1108_5
crossref_primary_10_1097_MNM_0b013e32834de94e
crossref_primary_10_1016_j_nbd_2012_11_002
crossref_primary_10_1097_RLU_0000000000002068
crossref_primary_10_1097_00006231_200212000_00007
Cites_doi 10.1038/290514a0
10.1007/BF00340846
10.1038/jcbfm.1985.24
10.1016/0006-8993(82)90833-2
10.1016/0883-2897(89)90158-X
10.1097/00006231-199506000-00004
10.1016/0022-3956(85)90080-9
10.1038/jcbfm.1987.12
10.1002/ana.410060502
10.1002/ana.410110509
10.1161/str.21.10.2219203
10.1016/0006-8993(83)90276-7
10.1136/jnnp.59.4.420
10.1016/0014-2999(85)90218-3
10.1097/00004728-198012000-00001
10.3171/jns.1981.54.6.0773
10.1016/0024-3205(90)90182-Q
10.1007/BF00232579
10.1016/0006-8993(79)90060-X
10.1161/str.24.12.8248987
10.1038/jcbfm.1983.67
10.1161/str.17.5.3532434
10.1007/BF00950756
ContentType Journal Article
Copyright 1997 INIST-CNRS
Copyright_xml – notice: 1997 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1161/01.STR.28.9.1776
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4628
EndPage 1782
ExternalDocumentID 9303025
2812255
10_1161_01_STR_28_9_1776
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GroupedDBID ---
.3C
.55
.GJ
.XZ
.Z2
01R
0R~
123
1J1
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
5RE
5VS
6PF
71W
77Y
7O~
A9M
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AAQQT
AARTV
AASCR
AASOK
AAUEB
AAXQO
AAYEP
AAYJJ
AAYXX
ABASU
ABBUW
ABDIG
ABJNI
ABPXF
ABQRW
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACCJW
ACDDN
ACDOF
ACEWG
ACGFS
ACGOD
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADFPA
ADGGA
ADGHP
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFBFQ
AFDTB
AFEXH
AFFNX
AFMBP
AFNMH
AFSOK
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHQVU
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
AYCSE
BAWUL
BCGUY
BOYCO
BQLVK
BS7
C45
CITATION
CS3
DIK
DIWNM
DU5
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GNXGY
GQDEL
GX1
H0~
H13
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
M18
N4W
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OB3
OCUKA
ODA
ODMTH
OGROG
OHYEH
OK1
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PQQKQ
R58
RAH
RIG
RLZ
S4R
S4S
T8P
TEORI
TSPGW
V2I
VVN
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YHZ
YQJ
YYP
ZB8
ZGI
ZZMQN
IQODW
ACIJW
AWKKM
CGR
CUY
CVF
ECM
EIF
NPM
OJAPA
OLW
RHF
YCJ
7X8
ID FETCH-LOGICAL-c359t-103761ea0619ed4ea103179376e48b651596e60cb9b6ff54a3327a592af987243
ISSN 0039-2499
IngestDate Thu Jul 10 18:05:24 EDT 2025
Wed Feb 19 02:32:43 EST 2025
Mon Jul 21 09:13:55 EDT 2025
Tue Jul 01 03:03:59 EDT 2025
Thu Apr 24 22:59:43 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Radionuclide study
Human
Nervous system diseases
Stroke
Radiolabelling
Cardiovascular disease
Exploration
Benzodiazepine receptor
Radioisotope
Iomazenil(123I)
Photon
Cerebral disorder
Vascular disease
Ischemia
Central nervous system disease
Cerebrovascular disease
Comparative study
Iodine
Positron
Emission tomography
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c359t-103761ea0619ed4ea103179376e48b651596e60cb9b6ff54a3327a592af987243
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 9303025
PQID 79298836
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_79298836
pubmed_primary_9303025
pascalfrancis_primary_2812255
crossref_primary_10_1161_01_STR_28_9_1776
crossref_citationtrail_10_1161_01_STR_28_9_1776
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1997-09-01
PublicationDateYYYYMMDD 1997-09-01
PublicationDate_xml – month: 09
  year: 1997
  text: 1997-09-01
  day: 01
PublicationDecade 1990
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
PublicationTitle Stroke (1970)
PublicationTitleAlternate Stroke
PublicationYear 1997
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References (e_1_3_2_14_2) 1990; 50
e_1_3_2_28_2
(e_1_3_2_15_2) 1995; 36
e_1_3_2_29_2
(e_1_3_2_27_2) 1995; 32
e_1_3_2_20_2
e_1_3_2_21_2
(e_1_3_2_22_2) 1995; 2
e_1_3_2_23_2
e_1_3_2_24_2
(e_1_3_2_10_2) 1990; 31
e_1_3_2_9_2
e_1_3_2_8_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_19_2
e_1_3_2_1_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_31_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_2_2
e_1_3_2_35_2
(e_1_3_2_5_2) 1986; 27
(e_1_3_2_12_2) 1992; 13
(e_1_3_2_26_2) 1994; 35
(e_1_3_2_16_2) 1988; 29
(e_1_3_2_25_2) 1991; 32
References_xml – ident: e_1_3_2_2_2
  doi: 10.1038/290514a0
– ident: e_1_3_2_36_2
  doi: 10.1007/BF00340846
– ident: e_1_3_2_21_2
  doi: 10.1038/jcbfm.1985.24
– ident: e_1_3_2_33_2
  doi: 10.1016/0006-8993(82)90833-2
– ident: e_1_3_2_6_2
  doi: 10.1016/0883-2897(89)90158-X
– ident: e_1_3_2_37_2
  doi: 10.1097/00006231-199506000-00004
– ident: e_1_3_2_8_2
  doi: 10.1016/0022-3956(85)90080-9
– ident: e_1_3_2_29_2
  doi: 10.1038/jcbfm.1987.12
– ident: e_1_3_2_20_2
  doi: 10.1002/ana.410060502
– volume: 27
  start-page: 1593
  year: 1986
  ident: e_1_3_2_5_2
  publication-title: J Nucl Med
– ident: e_1_3_2_31_2
– ident: e_1_3_2_34_2
  doi: 10.1002/ana.410110509
– ident: e_1_3_2_23_2
  doi: 10.1161/str.21.10.2219203
– volume: 32
  start-page: 1754
  year: 1991
  ident: e_1_3_2_25_2
  publication-title: J Nucl Med
– volume: 29
  start-page: 877
  year: 1988
  ident: e_1_3_2_16_2
  publication-title: J Nucl Med.
– ident: e_1_3_2_4_2
  doi: 10.1016/0006-8993(83)90276-7
– ident: e_1_3_2_35_2
  doi: 10.1136/jnnp.59.4.420
– ident: e_1_3_2_7_2
  doi: 10.1016/0014-2999(85)90218-3
– volume: 50
  start-page: 95
  year: 1990
  ident: e_1_3_2_14_2
  publication-title: Acta Neurochir Suppl Wien
– volume: 36
  start-page: 2154
  year: 1995
  ident: e_1_3_2_15_2
  publication-title: J Nucl Med
– ident: e_1_3_2_18_2
  doi: 10.1097/00004728-198012000-00001
– volume: 13
  start-page: 249
  year: 1992
  ident: e_1_3_2_12_2
  publication-title: AJNR Am J Neuroradiol
– ident: e_1_3_2_17_2
– ident: e_1_3_2_30_2
  doi: 10.3171/jns.1981.54.6.0773
– ident: e_1_3_2_11_2
  doi: 10.1016/0024-3205(90)90182-Q
– volume: 32
  start-page: 87
  year: 1995
  ident: e_1_3_2_27_2
  publication-title: Kaku Igaku
– ident: e_1_3_2_1_2
  doi: 10.1007/BF00232579
– ident: e_1_3_2_3_2
  doi: 10.1016/0006-8993(79)90060-X
– ident: e_1_3_2_24_2
– volume: 31
  start-page: 1007
  year: 1990
  ident: e_1_3_2_10_2
  publication-title: J Nucl Med
– volume: 35
  start-page: 228
  year: 1994
  ident: e_1_3_2_26_2
  publication-title: J Nucl Med
– volume: 2
  start-page: 165
  year: 1995
  ident: e_1_3_2_22_2
  publication-title: Hum Brain Mapping
– ident: e_1_3_2_9_2
  doi: 10.1161/str.24.12.8248987
– ident: e_1_3_2_32_2
– ident: e_1_3_2_19_2
  doi: 10.1038/jcbfm.1983.67
– ident: e_1_3_2_28_2
  doi: 10.1161/str.17.5.3532434
– ident: e_1_3_2_13_2
  doi: 10.1007/BF00950756
SSID ssj0002385
Score 1.727374
Snippet Background and Purpose [ 123 I]Iomazenil (IMZ) is a tracer used for single-photon emission computed tomography (SPECT) that has the characteristics of...
[123I]Iomazenil (IMZ) is a tracer used for single-photon emission computed tomography (SPECT) that has the characteristics of selectively binding to central...
SourceID proquest
pubmed
pascalfrancis
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 1776
SubjectTerms Aged
Biological and medical sciences
Brain - diagnostic imaging
Brain - metabolism
Brain Ischemia - diagnostic imaging
Brain Ischemia - metabolism
Flumazenil - analogs & derivatives
Humans
Investigative techniques, diagnostic techniques (general aspects)
Iodine Radioisotopes
Male
Medical sciences
Middle Aged
Nervous system
Radiography
Radionuclide investigations
Receptors, GABA-A - metabolism
Tomography, Emission-Computed
Tomography, Emission-Computed, Single-Photon
Subtitle A Comparison With PET Study
Title Assessment of Benzodiazepine Receptors Using Iodine-123–Labeled Iomazenil Single-Photon Emission Computed Tomography in Patients With Ischemic Cerebrovascular Disease
URI https://www.ncbi.nlm.nih.gov/pubmed/9303025
https://www.proquest.com/docview/79298836
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBASQtwmCgz8wAuakuXiOPFjBa0m2MZlqdQ3y0kdrVqbVF3yQH8J_4c_xrHjJM3G_SWqXDuqer4cfyc-53wIvY4EmbMsiCxJMmkRkiQW87LACnzqyBAeLqn7bJ-e0eMpeT8LZoPBt52spapM7HT707qS_7EqjIFdVZXsP1i2vSkMwGewL1zBwnD9KxuP2raaivMlMt8WYO6tXCvqCK5MrrWWTqXfByzgu1xasIdYYHnYbeYwtILZ-WJ5qGYspbW-KFSbDaUBp96i6YTzSnHSsliZ3taHXTNWUxm3gABZp9incgMRdpfcag5_bHA-aSd3qNd8Gsc7nW0NOT4vN8Wl5rwuC52ddxTvTN5wS7sn1WX1VaxEr7riTCSiFLXqeyc4BrOU3ks3ODc1f2Gbw9W6bV8dA9VKSo3b9qIdeLIdH-yGtaLMzc2Burrgwb4qN7YX2cxupvb7cJ995JPpyQmPx7P4FrrtQQCiXP6Hz10feiA6tTaG-WHNATh1j67fv0d47q3BBGKZ1aIpv45qNLuJH6D7JizBoxpjD9FA5o_QnVOTePEYfe-ghosM96GGW6hhDTV8E2q4hRruQQ03UMMN1HAHNbzIcQM1rGCDG6jha1DDDdTwCHdQq9cA1LCG2hM0nYzjt8eW0f-wUj9gpaVKWKkrBVBOJudECiVJovo5UkmihComTiV10oQlNMsCInzfC0XAPJGxKPSIv4_28iKXTxEWmUh9kYL3cTLd4tIhVMIf4BGapEDKh-ioMRJPTXN8pdGy5DpIpi53XH4ef-FexBlXZh2iN-2Kdd0Y5jdzD3p2bxfA8wT7aTBErxoccPjX1ZGdyGVRXfEQopco8uEO-zU82qUMuCfEK8_-uPQ5uts9Uy_QXrmp5AEQ6TJ5qTH9A_f60ig
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessment+of+benzodiazepine+receptors+using+iodine-123-labeled+iomazenil+single-photon+emission+computed+tomography+in+patients+with+ischemic+cerebrovascular+disease.+A+comparison+with+PET+study&rft.jtitle=Stroke+%281970%29&rft.au=Dong%2C+Y&rft.au=Fukuyama%2C+H&rft.au=Nabatame%2C+H&rft.au=Yamauchi%2C+H&rft.date=1997-09-01&rft.issn=0039-2499&rft.volume=28&rft.issue=9&rft.spage=1776&rft_id=info:doi/10.1161%2F01.str.28.9.1776&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-2499&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-2499&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-2499&client=summon